Learn how to organize your inbox, customize settings, and use AI tools in Outlook to boost productivity with this ...
1don MSN
Okeanis Eco Tankers signals $80,700 per day Q4 bookings as spot strategy drives dividend focus
The CEO highlighted that Okeanis Eco Tankers continues to focus on maximizing shareholder value, declaring its 14th consecutive dividend at $0.75 per share and distributing 100% of reported EPS this ...
TipRanks on MSN
Calavo Growers Announces CEO Retirement and Successor
On November 12, 2025, Calavo Growers announced the retirement of Lee E. Cole as President and CEO, effective December 8, 2025, after four decades of leadership. B. John Lindeman, a current board ...
It’s clear that EU food and beverage exporters are reconsidering their approach to the US market as tariffs and the weaker ...
Digital auto insurance company Root (NASDAQ:ROOT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 26.9% year on year to $387.8 million. Its GAAP loss of $0.35 per share was 35.7% ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
On November 6, 2025, DNOW Inc. completed its acquisition of MRC Global Inc., creating a premier solutions provider in the energy and industrial markets. The merger, which converted MRC Global’s common ...
For 2025, Fossil made every country list surveyed, ranking as the number one watch brand in Germany, number two in the US, ...
Gross margin -- 57.9%, which declined by 250 basis points year over year because of product mix shifts and elevated ...
Zacks Investment Research on MSN
Here's Why Cencora (COR) is a Strong Growth Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...
The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results